UNSPSC 85573109: Revision of infusion device in left lung, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in left lung, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0BWLX3Z

UNSPSC 85573109 Revision of infusion device in left lung, external approach (Commodity) shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's technical medical device descriptor does not match the actual work being solicited under this tag in the market today. Recent opportunities posted under this code span occupational medical surveillance, independent medical evaluations for pension disability determinations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out networks, and youth detention healthcare services — none of which involve infusion device revision or pulmonary intervention. This suggests either a data classification error in how opportunities are tagged to the UNSPSC hierarchy or a systematic mismatch between the code's intended scope and its application by state and local procurement offices.

State and local issuing bodies across Arizona, California, Florida, and Washington have posted opportunities under this code covering medical administration, benefit management, and occupational health services rather than medical device procurement. The City of Phoenix Retirement Office posted an RFP for independent medical evaluation services with a proposal deadline of October 16, 2026; the Washington State Department of Transportation posted an RFP for occupational medical surveillance with a response deadline of October 9, 2026 and a pre-bid conference on August 31, 2026; and the County of Santa Clara Health System posted an RFSQ for temporary health professional staffing services due October 7, 2026. Without recent opportunities genuinely targeting infusion device revision or similar interventional equipment procurement under this code, the code presents limited decision-relevant activity for vendors supplying medical devices or device-related services.